Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors.

Miriam Mengoni Andreas Dominik Braun Mattes Simon HinnerichsAnar AghayevThomas Tüting Alexey Surov

Published in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)

Our study represents the first exploratory study evaluating the suitability of body composition measurements as biomarkers for melanoma patients treated with TKI. Our data suggest a putative use of VATGI as a biomarker predicting patient outcome.

Keyphrases

body composition
resistance training
bone mineral density

case report
tyrosine kinase
big data

advanced non small cell lung cancer
skin cancer

epidermal growth factor receptor
basal cell carcinoma